The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Yanay Yaky since 2011.
The trader's CIK number is 1402539.
At the time of the last reporting, Yanay Yaky was the Chief Financial Officer of Pluristem Therapeutics Inc. (stock ticker symbol PSTI).
Also see all insider trading activities at Pluristem Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | PSTI | 71,429 | $50,000 | 0 | $0 | 0 | $0 |
| 2016 | PSTI | 25,000 | $24,390 | 0 | $0 | 0 | $0 |
| 2015 | PSTI | 30,000 | $57,360 | 0 | $0 | 0 | $0 |
| 2014 | PSTI | 32,000 | $89,715 | 100,000 | $428,120 | 0 | $0 |
| 2012 | PSTI | 0 | $0 | 16,927 | $84,635 | 0 | $0 |
| 2011 | PSTI | 0 | $0 | 25,000 | $74,000 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-04-08 | PSTI | Buy | 71,429 | .70 | 50,000 |
| 2016-02-18 | PSTI | Buy | 5,000 | 1.20 | 6,000 |
| 2016-02-16 | PSTI | Buy | 15,000 | .95 | 14,250 |
| 2016-02-12 | PSTI | Buy | 5,000 | .83 | 4,140 |
| 2015-11-16 | PSTI | Buy | 10,000 | 1.52 | 15,200 |
| 2015-09-21 | PSTI | Buy | 10,000 | 2.11 | 21,100 |
| 2015-09-16 | PSTI | Buy | 10,000 | 2.11 | 21,060 |
| 2014-11-11 | PSTI | Buy | 11,000 | 2.62 | 28,765 |
| 2014-09-22 | PSTI | Buy | 11,000 | 2.95 | 32,450 |
| 2014-09-16 | PSTI | Buy | 10,000 | 2.85 | 28,500 |
| 2014-01-10 | PSTI | Sale | 2,000 | 4.25 | 8,500 |
| 2014-01-13 | PSTI | Sale | 67,850 | 4.30 | 291,483 |
| 2014-01-08 | PSTI | Sale | 30,000 | 4.25 | 127,500 |
| 2014-01-09 | PSTI | Sale | 150 | 4.25 | 637 |
| 2012-08-17 | PSTI | Sale | 16,927 | 5.00 | 84,635 |
| 2011-01-18 | PSTI | Sale | 15,000 | 3.20 | 48,000 |
| 2011-01-11 | PSTI | Sale | 10,000 | 2.60 | 26,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yanay Yaky (Chief Financial Officer of Pluristem Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.